Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study
CONCLUSION: Lupus anticoagulant on admission is strongly associated with thrombosis in critically ill patients with COVID-19, especially in patients aged less than 65 years.PMID:36178455 | PMC:PMC9481876 | DOI:10.1002/rth2.12809
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Tessa Noordermeer Roger E G Schutgens Chantal Visser Emma Rademaker Moniek P M de Maat A J Gerard Jansen Maarten Limper Olaf L Cremer Marieke J H A Kruip Henrik Endeman Coen Maas Bas de Laat Rolf T Urbanus Dutch COVID & Thrombosis Coalition (DCTC) Source Type: research
More News: Antiphospholipid Syndrome | Coronavirus | COVID-19 | Hematology | Hughes Syndrome | Intensive Care | Lupus | Netherlands Health | Study | Thrombosis